These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 10101723)

  • 1. Growth hormone response to baclofen in patients with seasonal affective disorder: effects of light therapy.
    Shiah IS; Robertson HA; Lam RW; Yatham LN; Tam EM; Zis AP
    Psychoneuroendocrinology; 1999 Feb; 24(2):143-53. PubMed ID: 10101723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone response to sumatriptan (5-HT1D agonist) challenge in seasonal affective disorder: effects of light therapy.
    Yatham LN; Lam RW; Zis AP
    Biol Psychiatry; 1997 Jul; 42(1):24-9. PubMed ID: 9193738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone response to baclofen in patients with mania: a pilot study.
    Shiah IS; Yatham LN; Lam RW; Tam EM; Zis AP
    Psychopharmacology (Berl); 1999 Dec; 147(3):280-4. PubMed ID: 10639686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of meta-chlorophenylpiperazine infusions in patients with seasonal affective disorder and healthy control subjects. Diurnal responses and nocturnal regulatory mechanisms.
    Schwartz PJ; Murphy DL; Wehr TA; Garcia-Borreguero D; Oren DA; Moul DE; Ozaki N; Snelbaker AJ; Rosenthal NE
    Arch Gen Psychiatry; 1997 Apr; 54(4):375-85. PubMed ID: 9107154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone response to the GABAB agonist baclofen in major depressive disorder.
    Davis LL; Trivedi M; Choate A; Kramer GL; Petty F
    Psychoneuroendocrinology; 1997 Apr; 22(3):129-40. PubMed ID: 9203224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone response to the GABA-B agonist baclofen in 3-week abstinent alcoholics.
    Ozsoy S; Esel E; Turan T; Kula M
    Alcohol; 2007 Dec; 41(8):551-6. PubMed ID: 18047908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Divalproex sodium attenuates growth hormone response to baclofen in healthy human males.
    Shiah IS; Yatham LN; Lam RW; Zis AP
    Neuropsychopharmacology; 1998 May; 18(5):370-6. PubMed ID: 9536450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A preliminary study of baclofen-induced growth hormone release in generalised social phobia.
    Condren RM; Lucey JV; Thakore JH
    Hum Psychopharmacol; 2003 Mar; 18(2):125-30. PubMed ID: 12590406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune-inflammatory markers in patients with seasonal affective disorder: effects of light therapy.
    Leu SJ; Shiah IS; Yatham LN; Cheu YM; Lam RW
    J Affect Disord; 2001 Mar; 63(1-3):27-34. PubMed ID: 11246077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of phototherapy on electrooculographic ratio in winter seasonal affective disorder.
    Ozaki N; Rosenthal NE; Moul DE; Schwartz PJ; Oren DA
    Psychiatry Res; 1993 Nov; 49(2):99-107. PubMed ID: 8153191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone responses to GABAB receptor challenge with baclofen and impulsivity in healthy control and personality disorder subjects.
    Lee R; Chong B; Coccaro E
    Psychopharmacology (Berl); 2011 May; 215(1):41-8. PubMed ID: 21181128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced inflammatory and T-helper-1 type responses but suppressed lymphocyte proliferation in patients with seasonal affective disorder and treated by light therapy.
    Song C; Luchtman D; Kang Z; Tam EM; Yatham LN; Su KP; Lam RW
    J Affect Disord; 2015 Oct; 185():90-6. PubMed ID: 26148465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seasonal affective disorder: response to light as measured by electroencephalogram, melatonin suppression, and cerebral blood flow.
    Murphy DG; Murphy DM; Abbas M; Palazidou E; Binnie C; Arendt J; Campos Costa D; Checkley SA
    Br J Psychiatry; 1993 Sep; 163():327-31, 335-7. PubMed ID: 8401961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcoholism abolishes the gamma-aminobutyric acid (GABA)ergic control of GH secretion in humans.
    Vescovi PP; Volpi R; Coiro V
    Alcohol; 1998 Nov; 16(4):325-8. PubMed ID: 9818985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreasing TSH levels in patients with Seasonal Affective Disorder (SAD) responding to 1 week of bright light therapy.
    Martiny K; Simonsen C; Lunde M; Clemmensen L; Bech P
    J Affect Disord; 2004 Apr; 79(1-3):253-7. PubMed ID: 15023503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of depressive symptom remission during the treatment of seasonal affective disorder with cognitive-behavioral therapy or light therapy.
    Meyerhoff J; Young MA; Rohan KJ
    Depress Anxiety; 2018 May; 35(5):457-467. PubMed ID: 29659120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GABAB receptor-mediated inhibition of GABAA receptor calcium elevations in developing hypothalamic neurons.
    Obrietan K; van den Pol AN
    J Neurophysiol; 1998 Mar; 79(3):1360-70. PubMed ID: 9497417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GABAB receptors presynaptically modulate excitatory synaptic transmission in the rat supraoptic nucleus in vitro.
    Kombian SB; Zidichouski JA; Pittman QJ
    J Neurophysiol; 1996 Aug; 76(2):1166-79. PubMed ID: 8871228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological discrimination between gamma-aminobutyric acid type B receptors regulating cholecystokinin and somatostatin release from rat neocortex synaptosomes.
    Gemignani A; Paudice P; Bonanno G; Raiteri M
    Mol Pharmacol; 1994 Sep; 46(3):558-62. PubMed ID: 7935338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-response relationship of phototherapy for seasonal affective disorder: a meta-analysis.
    Lee TM; Chan CC
    Acta Psychiatr Scand; 1999 May; 99(5):315-23. PubMed ID: 10353446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.